Neural antibodies can specifically label and recognize molecules on nerve cells, enabling a more comprehensive understanding and study of the biological properties, functions, and mechanisms of nerve cells in neurodegenerative diseases.
Covering iPSC neural cells, brain organoids, and microelectrode array services, our tools support neural development, disease modeling, and drug screening with high quality and reliable performance to meet diverse research needs.
Name:Prothrombin Target Synonym:Prothrombin,EC:3.4.21.5,THPH1,Coagulation Factor II,Prepro-Coagulation Factor II,F2,Serine Protease,EC 3.4.21.5,PT,RPRGL2,EC 3.4.21,Coagulation Factor II, Thrombin,Coagulation Factor II (Thrombin),Thrombin Factor II,Prothrombin B-Chain
Number of Launched Drugs:55 Number of Drugs in Clinical Trials:15 Lastest Research Phase:Approved
Product Inquiry
* We couldn't find what you're looking for. You can let us help by filling the form below. Our
tech team will get back to you shortly.
* This form is only used to collect product demand consultation. All the information
will be kept strictly confidential.
Synonym Name
thrombin,Coagulation factor II
Background
Prothrombin is also known as coagulation factor II (F2),which can be cleaved into the following 4 chains: activation peptide fragment 1, activation peptide fragment 2, thrombin light chain and thrombin heavy chain. Coagulation factor II (F2) is able to form a heterodimer with SERPINA5. The mutations of F2 gene can result in a very rare blood coagulation disorder characterized by mucocutaneous bleeding symptoms. Furthermore, thrombin converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Coagulation factor II (F2) can also play an important role in blood homeostasis, inflammation and wound healing.